Prostate Cancer is the most common form of cancer in men.
There are 47,000 new registrations of prostate cancer each year and 15,000 deaths each year. There is also a 1 in 4 risk for African and African Caribbean men and for those with family history of the disease.
The Uro-Oncology team at the QE have world leading expertise in the management of men with advanced prostate cancer with the ground-breaking STAMPEDE trial (www.stampedetrial.org) being led by Prof James. The trial has already led to major changes in the care of men with advanced prostate cancer and to date more than 9000 men have been recruited to the study. The team at the Queen Elizabeth Hospital Birmingham (QEHB) and researchers at the University of Birmingham is dedicated to providing the best care possible for patients at QEHB.
Having one of the largest and most diverse cultural catchment areas in Europe QEHB is ideally set up to carry out this work.
The Prostate Cancer Appeal has the following aims: 1) To provide new innovative equipment for cancer treatments 2) To further develop research through clinical trials 3) To provide...
Find out more >In 2018, UHB Charity launched an ambitious new project to create a 'Man Van'. This van would be a mobile health unit, and would move around the West Midlands, empowering men to talk about...
Find out more >
